SE7704536L - PROCEDURE FOR THE PREPARATION OF PHENYL PIPERAZINE DERIVATIVES - Google Patents

PROCEDURE FOR THE PREPARATION OF PHENYL PIPERAZINE DERIVATIVES

Info

Publication number
SE7704536L
SE7704536L SE7704536A SE7704536A SE7704536L SE 7704536 L SE7704536 L SE 7704536L SE 7704536 A SE7704536 A SE 7704536A SE 7704536 A SE7704536 A SE 7704536A SE 7704536 L SE7704536 L SE 7704536L
Authority
SE
Sweden
Prior art keywords
formula
preparation
procedure
group
vii
Prior art date
Application number
SE7704536A
Other languages
Swedish (sv)
Inventor
J P Verge
W B Jamieson
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of SE7704536L publication Critical patent/SE7704536L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Abstract

Phenylpiperazine derivatives of formula (I) <IMAGE> as well as their pharmaceutically acceptable salts, are prepared. R<1> represents benzyl, C1-6 alkyl or an optionally substituted phenyl; R<2> represents an optionally substituted phenyl, R<3> represents hydrogen or C1-4 alkyl, Q represents furan, thiophene, oxazole or thiazole, m is an integer from 1 to 3 and n is 0 or 1. When m is 2 and n is 0, R<1> cannot represent a methyl group when Q is the thiazol-5-yl group. The preparation is carried out by condensation of a compound of formula (VII): R<1>-Q-(CH2)m-(CHR<3>)n-L (VII) in which L represents the split group, with a compound of formula (VIII): <IMAGE> The compounds of formula (I) and their pharmaceutically acceptable salts are useful in the prophylactic and therapeutic treatment of diseases of immediate hypersensitiveness, especially asthma in mammals. They have a low toxicity.
SE7704536A 1976-04-23 1977-04-20 PROCEDURE FOR THE PREPARATION OF PHENYL PIPERAZINE DERIVATIVES SE7704536L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
SE7704536L true SE7704536L (en) 1977-10-24

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704536A SE7704536L (en) 1976-04-23 1977-04-20 PROCEDURE FOR THE PREPARATION OF PHENYL PIPERAZINE DERIVATIVES

Country Status (34)

Country Link
JP (1) JPS52151183A (en)
AR (2) AR222003A1 (en)
AT (1) AT355579B (en)
AU (1) AU514822B2 (en)
BE (1) BE853899A (en)
BG (2) BG28055A3 (en)
CA (1) CA1087617A (en)
CH (2) CH633009A5 (en)
CS (1) CS196360B2 (en)
DD (1) DD129790A5 (en)
DE (1) DE2717415A1 (en)
DK (1) DK176177A (en)
ES (2) ES457988A1 (en)
FI (1) FI63937C (en)
FR (1) FR2348925A1 (en)
GB (1) GB1575904A (en)
GR (1) GR64084B (en)
HU (1) HU176820B (en)
IE (1) IE44730B1 (en)
IL (1) IL51787A (en)
LU (1) LU77170A1 (en)
MX (1) MX4596E (en)
NL (1) NL7704456A (en)
NO (1) NO146710C (en)
NZ (1) NZ183715A (en)
OA (1) OA05643A (en)
PH (1) PH14124A (en)
PL (1) PL117466B1 (en)
PT (1) PT66452B (en)
RO (1) RO72831A (en)
SE (1) SE7704536L (en)
SU (2) SU664564A3 (en)
YU (1) YU104477A (en)
ZA (1) ZA771849B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (en) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen POLYAZO DYES
JPH07157477A (en) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk Production of thiazole derivative
KR970701705A (en) * 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ receptor agonists, novel thiazole derivatives, and intermediates thereof
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
AU2007221021B2 (en) * 2006-02-28 2013-01-17 Dart Neuroscience (Cayman) Ltd Therapeutic piperazines as PDE4 inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
NO146710B (en) 1982-08-16
FI63937C (en) 1983-09-12
CS196360B2 (en) 1980-03-31
PH14124A (en) 1981-02-26
BG28055A3 (en) 1980-02-25
AT355579B (en) 1980-03-10
ATA285177A (en) 1979-08-15
AR222003A1 (en) 1981-04-15
FI771287A (en) 1977-10-24
ES457988A1 (en) 1978-07-16
DE2717415A1 (en) 1977-11-10
RO72831B (en) 1983-07-30
ZA771849B (en) 1978-11-29
AU2438677A (en) 1978-10-26
HU176820B (en) 1981-05-28
CH633009A5 (en) 1982-11-15
NZ183715A (en) 1980-04-28
RO72831A (en) 1983-08-03
AR222635A1 (en) 1981-06-15
PT66452A (en) 1977-05-01
SU664564A3 (en) 1979-05-25
DK176177A (en) 1977-10-24
FI63937B (en) 1983-05-31
JPS52151183A (en) 1977-12-15
IL51787A (en) 1980-02-29
AU514822B2 (en) 1981-02-26
FR2348925A1 (en) 1977-11-18
PL117466B1 (en) 1981-08-31
BG27746A3 (en) 1979-12-12
CA1087617A (en) 1980-10-14
PL197550A1 (en) 1979-05-21
OA05643A (en) 1981-04-30
NL7704456A (en) 1977-10-25
BE853899A (en) 1977-10-24
DD129790A5 (en) 1978-02-08
NO146710C (en) 1982-11-24
YU104477A (en) 1983-01-21
NO771398L (en) 1977-10-25
LU77170A1 (en) 1979-01-18
GB1575904A (en) 1980-10-01
GR64084B (en) 1980-01-21
ES467948A1 (en) 1978-11-01
CH625802A5 (en) 1981-10-15
IE44730L (en) 1977-10-23
SU727146A3 (en) 1980-04-05
MX4596E (en) 1982-06-25
IE44730B1 (en) 1982-03-10
IL51787A0 (en) 1977-05-31
PT66452B (en) 1979-03-09
FR2348925B1 (en) 1980-04-11

Similar Documents

Publication Publication Date Title
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
NO149888C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-SUBSTITUTED-2`-HYDROXYL-6,7-BENZOMORPHANES AND ACID ADDITION SALTS THEREOF
SE7908995L (en) Heterocyclic Associations
SE7905402L (en) PHENYL-PIPERAZINE DERIVATIVES
DE3777852D1 (en) DEKAHYDROCHINOLIN DERIVATIVES, METHOD FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS AND PREPARATIONS THEREOF.
SE8403801L (en) NEW BENZOTIAZEPINS WITH CARDIOVASCULAR APPLICABILITY, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SE7906472L (en) NEW 3- (AMINOETHYL) -PHENOL DERIVATIVES AND SALTS THEREOF, SET FOR PREPARATION AND USE OF THEM AS MEDICINAL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DE69311118D1 (en) PHOSPHONO-ARYLETHANOLAMINE COMPOUNDS WITH ANTI-HYPERGLYCEMIC AND / OR ANTIOBESIC EFFECT
SE7704536L (en) PROCEDURE FOR THE PREPARATION OF PHENYL PIPERAZINE DERIVATIVES
NO164351C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ALKYL-L-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS.
NO160445C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLIC COMPOUNDS.
DK37580A (en) 4,5-DIHYDRO-4-OXOFURAN-2-CARBOXYLIC ACID DERIVATIVES AND THEIR PREPARATION AND USE
SE7701187L (en) NEW PIPERAZINE DERIVATIVES AND WAY TO PRODUCE THE SAME
MX4767E (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1,8-ETHANO-5-OXO OCTA AND DECAHIDROQUINOLINES
IL61687A0 (en) Benzothiazole derivatives,pharmaceutical formulations containing them and a process for their preparation
ES8202818A1 (en) Tetrazolylcoumarin derivatives, process for preparing the same and composition containing the same.
SE8903312D0 (en) NEW 2-CARBONYL SUBSTITUTED N, N&#39;-DI- (TRIMETHOXYBENZOL) PIPERAZINES, PROCESS FOR PREPARING THE SAME AND THERAPEUTICAL COMPOUNDS CONTAINING THEM
SE8301785L (en) SET TO MAKE 2-THIOPHENIC ACETIC ACID DERIVATIVES AND INTERMEDIATES REQUIRED FOR THEIR PREPARATION
DK272684D0 (en) TETRAHYDRO-BETA CARBOLIN DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
DE2964850D1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
SE8400629D0 (en) NOVEL BASIC OXIME ETHERS AND A PROCESS FOR PREPARING SAME
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
SE7901034L (en) NEW ANILIDES WITH ANTITUSIVE EFFECT AND PROCEDURE FOR THEIR PREPARATION
SE7910387L (en) 7ALFA METOXICE PHALOSPORINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
SE8903313L (en) NEW 2-METOXICARBONYL-SUBSTITUTED N, N&#39;-DI- (TRIMETOXYBENZOYL) -PIPERAZINES, PROCEDURES FOR PREPARING THEREOF AND THERAPEUTIC SUBSTANCES CONTAINING THEM

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7704536-7